可调节经闭孔男性系统治疗经尿道前列腺电切术后压力性尿失禁
该研究基于国际前瞻性ATOMS登记数据库,纳入49例经尿道前列腺电切术(TURP)后持续压力性尿失禁并植入ATOMS装置的男性,分为标准TURP(sTURP)与放疗患者姑息性TURP(pTURP)两组。中位随访34个月和22个月、经2-3次调节后,sTURP组与pTURP组干爽率分别为58%和50%,成功率分别为90%和87%。pTURP组移除率更高(50% vs 10%,P=0.0171),感染为最常见副作用(50%)。
要点
- sTURP组与pTURP组干爽率分别为58%和50%,成功率分别为90%和87%。
- pTURP组移除率50% vs sTURP组10%(P=0.0171),感染为最常见副作用(50%)。
- 两组每日尿垫数和尿垫试验均显著改善(均P<0.001),生活质量满意度高。
核心结论
- ATOMS装置在TURP术后患者中显示出有希望的治疗结果,疗效与前列腺切除术后尿失禁相似。
- sTURP与pTURP两组控尿结果无差异,但pTURP组移除率更高,可能对患者咨询有重要意义。
研究设计与样本
- 从大型国际前瞻性管理的ATOMS登记数据库中识别49例因TURP后持续压力性尿失禁而植入ATOMS装置的患者。
- 按标准TURP(sTURP)与放疗患者姑息性TURP(pTURP)分组评估。
- 基线与随访评估包括控尿参数、尿动力学、生活质量调查(患者整体印象改善和国际尿失禁咨询问卷简表)及疼痛评分。
主要发现
- sTURP组和pTURP组中位随访分别为34个月和22个月、经2-3次调节后,干爽率分别为58%和50%,成功率分别为90%和87%,无改善率分别为10%和13%。
- pTURP组移除率高于sTURP组(50% vs 10%,P=0.0171),感染为最常见副作用(50%)。
- 未记录术中及Clavien-Dindo 4级和5级不良事件。
- sTURP组和pTURP组中位每日尿垫数和尿垫试验均显著改善(均P<0.001),生活质量参数转向高满意度水平(P<0.001和P=0.001)。
- 尿动力学保持不变,术后疼痛不是问题。
关键数值与推荐
- 干爽定义为0-1块安全尿垫/<10 mL尿失禁。
- 成功率定义为总体改善。
- P值<0.05认为有统计学显著性。
临床怎么用
- 作者结论认为ATOMS装置在TURP术后患者中显示出有希望的治疗结果,疗效与前列腺切除术后尿失禁相似。
- 作者指出sTURP与pTURP两组控尿结果无差异,但pTURP组移除率更高,可能对患者咨询有重要意义。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To investigate the efficacy and safety of the Adjustable Transobturator Male System (ATOMS) in men with stress urinary incontinence after transurethral resection of the prostate (TURP). MATERIALS AND METHODS: From a large international prospectively administrated ATOMS register, we identified 49 patients with an ATOMS device as a result of persistent stress urinary incontinence after TURP. For evaluation, the men were divided into standard transurethral resection of the prostate (sTURP) and palliative transurethral resection of the prostate (pTURP) in radiated patients. Baseline and follow-up measurements included continence parameters, urodynamics, quality-of-life surveys (Patient Global Impression-Improvement and International Consultation on Incontinence Questionnaire-Short Form), and pain ratings. The dry rate (0-1 security pad/<10 mL urine loss), the success rate (overall improvement), removals, complications, and treatment failures were recorded. A P value of <.05 was considered statistically significant. RESULTS: After a median of 34 and 22 months' follow-up and 2-3 adjustments, the sTURP and pTURP cohorts had 58% and 50% dry rates and 90% and 87% success rates. Hence, no improvement was seen in 10% and 13%. The removal rate was higher in pTURP (50% vs 10%, P = .0171) and infection was the most common side effect (50%) observed. Neither intraoperative nor Clavien-Dindo 4 and 5 adverse events were recorded. In sTURP and pTURP, the median daily pad count and the pad test improved significantly (all P <.001), and quality-of-life parameters shifted to a high satisfaction level (P <.001 and P = .001). Urodynamics remained unchanged and postoperative pain was not an issue. CONCLUSION: The ATOMS device shows promising treatment outcomes in patients after TURP and a similar efficacy as in postprostatectomy incontinence. There is no difference in continence outcome between sTURP and pTURP; however, a higher removal rate was found after pTURP, which may be important for patient counseling.
引用
- Friedl A, Schneeweiss J, Stangl K, et al. The Adjustable Transobturator Male System in Stress Urinary Incontinence After Transurethral Resection of the Prostate. Urology. 2017. PMID: 28712889. doi:10.1016/j.urology.2017.07.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。